SCHEMBL4060544

SCHEMBL4060544

Cc1ccc(CC(=O)O)cc1OCCc1nc(N2CCN(c3ccc(C(F)(F)F)cn3)CC2)sc1C

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 8/20 0.49
PPARG P37231 7/20 0.48
PPARA Q07869 6/20 0.48
SMN1; SMN2 Q16637 6/20 0.45
HPGD P15428 1/20 0.45
LMNA P02545 5/20 0.44
KDM4E B2RXH2 4/20 0.44
HTT P42858 3/20 0.44
CYP3A4 P08684 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPT P10636 3/20 0.42
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.40
SMO Q99835 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678793 0.86 SMN1; SMN2 (0.46) PPARDPPARGPPARASMN1; SMN2HPGD
SCHEMBL4061841 0.82 PPARD (0.55) PPARDPPARGPPARACYP3A4
SCHEMBL4061597 0.80 PPARD (0.61) PPARDPPARGPPARASMN1; SMN2CYP3A4
SCHEMBL4062758 0.78 PPARG (0.53) PPARDPPARGPPARACYP3A4
SCHEMBL4066110 0.78 PPARG (0.55) PPARDPPARGPPARACYP3A4
SCHEMBL4067797 0.76 PPARD (0.48) PPARDPPARGPPARACYP3A4MEN1
SCHEMBL4064895 0.76 PPARD (0.60) PPARDPPARGPPARACYP3A4
SCHEMBL10220166 0.75 PPARD (0.78) PPARDPPARGPPARACYP3A4
SCHEMBL4055838 0.75 PPARD (0.49) PPARDPPARGPPARAKDM4ECYP3A4
SCHEMBL4064821 0.74 PPARD (0.54) PPARDPPARGPPARACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1666472-B1 PHENYLACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE ONO PHARMACEUTICAL CO (JP) 2012-08-01 EP disclosed
US-7560475-B2 Phenylacetic acid derivative, process for producing the same, and use ONO PHARMACEUTICAL CO., LTD. (JP) 2009-07-14 US disclosed
US-20070105868-A1 Phenylacetic acid derivative, process for producing the same, and use ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US disclosed
EP-1666472-A1 PHENYLACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE ONO PHARMACEUTICAL CO., LTD. (JP) 2006-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105868-A1 Phenylacetic acid derivative, process for producing the same, and use PPARA, PPARD, PPARG PPARD 2/4885PPARG 3/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.